Author

M. Rubis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

J. L. Iovanna· 2 shared A. Cusimano· 1 shared A. Dereynies· 1 shared A. Listi· 1 shared B. Bournet· 1 shared C. Canivet· 1 shared C. L. Pin· 1 shared C. Vanbrugghe· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

J. L. Iovanna

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response

M. T. Borrello, M. Emma, A. Listi, M. Rubis, S. Coslet, G. Augello, A. Cusimano, D. Cabibi, R. Porcasi, L. Giannitrapani, M. Soresi, G. Pantuso, K. Blyth, G. Montalto, C. L. Pin, , J. L. Iovanna

This study shows NUPR1 protects the liver from lipotoxic injury by enhancing the endoplasmic reticulum stress response and regulating lipid homeostasis through PPAR- signaling.

bioRxiv · Oct 23, 2020Cell Biology

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

R. Nicolle, Y. Blum, P. Duconseil, C. Vanbrugghe, N. Brandone, F. Poizat, J. Roques, M. Bigonnet, O. Gayet, M. Rubis, N. Elarouci, L. Armenoult, M. Ayadi, A. Dereynies, M. Giovannini, , N. J. Dusetti

This paper develops a transcriptomic gradient (PAMG) to predict pancreatic cancer aggressiveness and treatment response using patient-derived xenografts and clinical data.

bioRxiv · Mar 25, 2020Cancer Biology